View Item 

Show simple item record

OUTCOMES FOR RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: WHAT REALLY MATTERS?

dc.contributor.authorMontie, James E.en_US
dc.contributor.authorHussain, Maha H. A.en_US
dc.date.accessioned2010-06-01T22:26:05Z
dc.date.available2010-06-01T22:26:05Z
dc.date.issued2007-09en_US
dc.identifier.citationMontie, James E.; Hussain, Maha (2007). "OUTCOMES FOR RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: WHAT REALLY MATTERS?." BJU International 100(3): 485-486. <http://hdl.handle.net/2027.42/75426>en_US
dc.identifier.issn1464-4096en_US
dc.identifier.issn1464-410Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75426
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17608823&dopt=citationen_US
dc.format.extent97385 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2007 THE AUTHORS; JOURNAL COMPILATION © 2007 BJU INTERNATIONALen_US
dc.titleOUTCOMES FOR RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: WHAT REALLY MATTERS?en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid17608823en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75426/1/j.1464-410X.2007.07057.x.pdf
dc.identifier.doi10.1111/j.1464-410X.2007.07057.xen_US
dc.identifier.sourceBJU Internationalen_US
dc.identifier.citedreferenceBolla M, Van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC Trial 22911). Lancet 2005; 366: 572 – 8en_US
dc.identifier.citedreferenceBolla M, Van Poppel H, Collette L, van der Kwast TH on behalf or EORTC Genito-Urinary and Radiation Oncology Groups. ASCO 2007 Prostate Cancer Symposium, Orlando, Florida, February 22–24, 2007en_US
dc.identifier.citedreferenceWirth MP, See WA, McLeod DG et al. Bicalutamide 150 MG in addition to standard care in patients with localized or locally advanced prostate cancer. results from the second analysis of the early prostate cancer program at median follow up of 5.4 years. J Urol 2004; 172: 1865 – 70en_US
dc.identifier.citedreference4  FDA Statement. Pfizer stops all torcetrapib clinical trials in interest of patient safety December 3, 2006 Available at http://www.fda.gov/bbs/topics/NEWS/2006/NEW01514.html Accessed May 2007en_US
dc.identifier.citedreferenceWilliams SD, Stablein DM, Einhorn LH et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathologic stage II testicular cancer. N Eng J Med 1987; 317: 1433 – 8en_US
dc.identifier.citedreferenceStephenson AJ, Shariat SF, Zelefsky MJ et al. salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004; 291: 1325 – 32en_US
dc.identifier.citedreferenceBuskirk SJ, Pisansly TM, Schild SE et al. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy. evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 2006; 176: 985 – 90en_US
dc.identifier.citedreferenceThompson I, Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer. JAMA 2006; 296: 2329 – 35en_US
dc.identifier.citedreferenceEggener SE, Roehl KA, Smith ND et al. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. J Urol 2005; 173: 1150 – 5en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1464-410X.2007.07057.x.pdf
Size:
95.10KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.